BRIEF published on 09/09/2024 at 22:06, 1 year 7 months ago Abivax financial results for the first half of 2024 Financial Results Biotechnology Abivax First Half Of 2024 Immune Mechanisms
PRESS RELEASE published on 09/09/2024 at 22:01, 1 year 7 months ago Abivax presents first-half 2024 financial results Abivax presents first-half 2024 financial results with a cash balance of EUR 222M at June 30, 2024. The company focuses on developing therapies for chronic inflammatory diseases Financial Results Abivax Therapeutics Chronic Inflammatory Diseases EUR 222M
PRESS RELEASE published on 09/09/2024 at 22:01, 1 year 7 months ago Abivax présente ses résultats financiers du premier semestre 2024 Abivax présente ses résultats financiers semestriels 2024 avec une trésorerie de 222 millions d'euros au 30 juin 2024, assurant le financement jusqu'au Q4 2025 Résultats Financiers Abivax Bilan Trésorerie Dépenses
BRIEF published on 08/29/2024 at 18:05, 1 year 8 months ago ABIVAX : État des actions et des droits de vote au 31 juillet 2024 Euronext Paris Droits De Vote Actions Abivax Réglementaire
BRIEF published on 08/29/2024 at 18:05, 1 year 8 months ago ABIVAX: Status of shares and voting rights as of July 31, 2024 Euronext Paris Voting Rights Actions Abivax Regulatory
PRESS RELEASE published on 08/29/2024 at 18:00, 1 year 8 months ago ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.07.24. ABIVAX annonce le nombre d'actions et de droits de vote au 31.07.24, conformément aux réglementations en vigueur Euronext Paris Droits De Vote Actions Abivax Règlement Général
BRIEF published on 08/06/2024 at 08:35, 1 year 9 months ago Abivax franchit une étape clé avec le recrutement de 600 patients pour l'essai de phase 3 ABTECT Abivax Obefazimod Rectocolite Hémorragique Essai Clinique Recrutement Patients
BRIEF published on 08/06/2024 at 08:35, 1 year 9 months ago Abivax Reaches Key Milestone with Recruitment of 600 Patients for Phase 3 ABTECT Trial Patient Recruitment Abivax Obefazimod Ulcerative Colitis Clinical Test
PRESS RELEASE published on 08/06/2024 at 08:30, 1 year 9 months ago Abivax franchit une étape clé avec le recrutement de 600 patients pour l'essai de phase 3 ABTECT Abivax franchit une étape clé avec le recrutement de 600 patients pour l'essai de phase 3 ABTECT, confirmant son avancement vers l'objectif de recrutement complet au premier trimestre 2025 Abivax Recrutement Essai Clinique Phase 3 ABTECT
PRESS RELEASE published on 08/06/2024 at 08:30, 1 year 9 months ago Abivax franchit une étape clé avec le recrutement de 600 patients pour l'essai de phase 3 ABTECT Abivax franchit une étape clé avec le recrutement de 600 patients pour l'essai de phase 3 ABTECT, confirmant l'évolution favorable du projet. La société réaffirme ses prévisions pour 2025 Abivax Recrutement Traitement Phase 3 ABTECT
Published on 05/07/2026 at 18:30, 6 minutes ago Silver Storm Announces Mobilization of Underground Mine Development Contractors at La Parrilla
Published on 05/07/2026 at 16:35, 2 hours 1 minute ago Caledonia Mining Corporation Plc New Corporate Video
Published on 05/07/2026 at 15:15, 3 hours 21 minutes ago ACCESS Newswire Launches ACCESS Insights & Analytics, AI-Powered Press Release Scoring Platform
Published on 05/07/2026 at 14:35, 4 hours 1 minute ago Worksport (NASDAQ: WKSP) Announces Q1 2026 Earnings Call Date and Launch of Investor Townhall Series
Published on 05/07/2026 at 14:30, 4 hours 6 minutes ago Rio Grande Resources Announces Results of First Annual General Meeting and Re-Appointments
Published on 05/07/2026 at 18:00, 35 minutes ago Correction d’un communiqué du 05.05.2026 21:46 CET/CEST - E-PANGO: Composition du capital au 30 avril 2026
Published on 05/07/2026 at 17:45, 50 minutes ago Swiss Life shareholders approve all resolutions proposed by the Board of Directors
Published on 05/07/2026 at 17:45, 50 minutes ago Annual General Meeting of SKAN Group AG approves all proposals
Published on 05/07/2026 at 17:45, 50 minutes ago Results of Annual Shareholders Meeting of R&S Group Holding AG
Published on 05/07/2026 at 18:17, 19 minutes ago DESCRIPTIF DU PROGRAMME DE RACHAT D’ACTIONS LOUIS HACHETTE GROUP 2026-2027
Published on 05/07/2026 at 18:17, 19 minutes ago DESCRIPTION OF THE LOUIS HACHETTE GROUP SHARE BUYBACK PROGRAM 2026-2027
Published on 05/07/2026 at 18:01, 34 minutes ago LNA SANTE : Chiffre d'affaires du 1er trimestre 2026
Published on 05/07/2026 at 17:45, 51 minutes ago INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
